Bayer Pulls Remaining Trasylol Supply

The anti-bleeding agent has been under an FDA-requested marketing suspension since last November.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet